{"id":150,"date":"2021-07-03T02:00:25","date_gmt":"2021-07-03T00:00:25","guid":{"rendered":"https:\/\/www.slsc.ch\/slsc\/?page_id=150"},"modified":"2021-07-13T13:06:42","modified_gmt":"2021-07-13T11:06:42","slug":"henk-streefkerk","status":"publish","type":"page","link":"https:\/\/www.slsc.ch\/slsc\/index.php\/henk-streefkerk\/","title":{"rendered":"Henk Streefkerk"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"aligncenter is-resized\"><img decoding=\"async\" loading=\"lazy\" src=\"http:\/\/slsc.ch\/slsc_internship2\/wp-content\/uploads\/2021\/06\/image.png\" alt=\"This image has an empty alt attribute; its file name is image.png\" width=\"150\" height=\"150\"\/><figcaption><strong>Henk Streefkerk, MD PhD<\/strong><\/figcaption><\/figure><\/div>\n\n\n\n<p>Number: +41 79 899 73 53<\/p>\n\n\n\n<p>E-mail: hendrik.streefkerk@gmail.com<\/p>\n\n\n\n<p>Henk Streefkerk is a physician (MD) with a PhD in Neurovascular surgery. He brings more than 15 years of experience in the pharmaceutical industry with all clinical activities in Clinical Trials (Phases I through IV), Investigator Initiated Trials, Compassionate Use Programs, as well as with multiple successful NDA\/MAA submissions resulting in marketing authorization (a.o., Entresto, Kisqali). He is also experienced with clinical safety and pharmacovigilance, and quality systems for clinical and safety procedures. He speaks fluently English, German and Dutch, and a little bit of French.<\/p>\n\n\n\n<p>Prior to joining SWConsultants, Dr Streefkerk served as Chief Medical Officer of PIQUR Therapeutics AG. He previously worked at Novartis, Actelion in the Basel area in Switzerland, and at Schering Plough \/ Organon in the Netherlands.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.slsc.ch\/slsc\/index.php\/cv-henk-streefkerk\/\" data-type=\"URL\" data-id=\"https:\/\/www.slsc.ch\/slsc\/index.php\/cv-henk-streefkerk\/\">CV&nbsp;<\/a>of Henk Streefkerk<\/p>\n\n\n\n<p>List of&nbsp;<a href=\"https:\/\/www.slsc.ch\/slsc\/index.php\/key-publications-henk-streefkerk\/\" data-type=\"URL\" data-id=\"https:\/\/www.slsc.ch\/slsc\/index.php\/key-publications-henk-streefkerk\/\">key publications<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Number: +41 79 899 73 53 E-mail: hendrik.streefkerk@gmail.com Henk Streefkerk is a physician (MD) with a PhD in Neurovascular surgery. He brings more than 15 years of experience in the pharmaceutical industry with all clinical activities in Clinical Trials (Phases [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"_links":{"self":[{"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/pages\/150"}],"collection":[{"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/comments?post=150"}],"version-history":[{"count":3,"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/pages\/150\/revisions"}],"predecessor-version":[{"id":206,"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/pages\/150\/revisions\/206"}],"wp:attachment":[{"href":"https:\/\/www.slsc.ch\/slsc\/index.php\/wp-json\/wp\/v2\/media?parent=150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}